Incazelo
I-Omeprazole yethu ephakathi kwe-2.3.5-Trimethyl-4-nitropyridine-N-oxide ikhiqizwa ngokucophelela ukuze ihlangabezane nezindinganiso eziphakeme kakhulu zemboni, iqinisekisa ubumsulwa bayo nokusebenza kwayo futhi ingasetshenziswa ezinqubweni ezihlukahlukene zamakhemikhali kanye nemithi.Ngokwakheka kwayo okunembayo kanye nekhwalithi eyingqayizivele, lesi sithako siyisinqumo esifanelekile sabacwaningi, ososayensi nochwepheshe bezemithi abafuna abaxhumanisi abathembekile, abasebenza kahle kakhulu kumaphrojekthi abo.
Lokhu okumaphakathi kudlala indima ebalulekile ekukhiqizweni kwe-omeprazole, umuthi osetshenziswa kabanzi ukwelapha izifo ezihlobene ne-asidi njenge-gastroesophageal reflux disease (GERD), izilonda ze-peptic, kanye ne-zolin (Guardian-Ellison syndrome).Njengengxenye eyinhloko ekuhlanganisweni kwe-omeprazole, i-omeprazole yethu emaphakathi engu-2.3.5-trimethyl-4-nitropyridine-N-oxide isiza ukukhiqizwa okuphumelelayo nokungabizi kwalo mithi ebalulekile.
Khetha Thina
I-JDK ingumnikazi wezindawo zokukhiqiza zekilasi lokuqala kanye nempahla yokuphatha Ikhwalithi, eqinisekisa ukuhlinzekwa okuzinzile kwama-API intermediates.Ithimba lochwepheshe liqinisekisa i-R&D ngomkhiqizo.Ngokuphikisana nakho kokubili, sifuna i-CMO & CDMO emakethe yasekhaya neyamazwe ngamazwe.
![I-Tofacitinib Intermediate (2R, 3R) -2,3-bis [(4-methylbenzoyl) oxy] succinic acid kanye (3R, 4R) – N, 4-dimethyl-1- (phenylmethyl) -3-piperidine amine CAS No. 477600 -71-8](http://cdn.globalso.com/jdkhc/2R-3R-23-bis-4-methylbenzoyl-oxy-succinic-acid-and-3R-4R-N-4-dimethyl-1-phenylmethyl-3-piperidine-amine.jpg)
